Recombinant Erythropoietin for Chemotherapy-Related Anaemia: Economic Value and Health-Related Quality-of-Life Assessment Using Direct Utility Elicitation and Discrete Choice Experiment Methods

Author： Ossa Diego F.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.25, Iss.3, 2007-01, pp. : 223-237

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Generic Health-Related Quality-of-Life Assessment in Children and Adolescents: Methodological Considerations

By Ravens-Sieberer Ulrike   Erhart Michael   Wille Nora  

PharmacoEconomics, Vol. 24, Iss. 12, 2006-01 ,pp. : 1199-1220

Adis International

Access to resources Recommend Favorite

A Review of Health-Related Quality-of-Life Measures in Stroke

By Golomb B.A.  

PharmacoEconomics, Vol. 19, Iss. 2, 2001-01 ,pp. : 155-185

Adis International

Access to resources Recommend Favorite

The Health-Related Quality of Life and Economic Burden of Constipation

By Dennison Cheryl  

PharmacoEconomics, Vol. 23, Iss. 5, 2005-01 ,pp. : 461-476

Adis International

Access to resources Recommend Favorite

Palliative chemotherapy is unlikely to be modified or discontinued because of health-related quality of life

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 354, 2002-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Recombinant erythropoietin favoured in chemo-related anaemia

By  

Inpharma, Vol. 1, Iss. 1587, 2007-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite